Fulcrum Therapeutics, Inc. (FULC)
NASDAQ·Healthcare·Biotechnology
$3.81
-0.91%
Mkt Cap $286.88M
Analyst Ratings
Buy
0
Hold
3
Sell
2
Price Target (31 analysts)
$3.60
Range $3.00 – $4.00
Implied Upside
-5.4%
Consensus $3.60 vs current $3.81
NASDAQ·Healthcare·Biotechnology
$3.81
-0.91%
Mkt Cap $286.88M
Buy
0
Hold
3
Sell
2
Price Target (31 analysts)
$3.60
Range $3.00 – $4.00
-5.4%
Consensus $3.60 vs current $3.81